What healthy lifestyle, healthy outcomes, and the role and responsibility of everybody in that. I mean, you're the patient, you're the provider, you're the researcher, you're the manufacturer. You're all. You're the federal government and the fda. The FDA has to be cautious, but it cannot be risk averse. Okay? Because if you allow any bureaucracy to just say no because some advisory panel said, well, we're not comfortable with this yet, and then you say no. Remember that for mdma, okay? (14:30–14:34)
CLAIM
Asserts that the FDA should balance caution with the need to avoid excessive risk aversion.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
